Agios Pharmaceuticals (AGIO) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Agios Pharmaceuticals (AGIO) over the last 14 years, with Q3 2025 value amounting to -$33.6 million.
- Agios Pharmaceuticals' Other Gross PP&E Adjustments rose 2659.41% to -$33.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$33.6 million, marking a year-over-year increase of 2659.41%. This contributed to the annual value of $4.2 million for FY2024, which is 15421.83% up from last year.
- Agios Pharmaceuticals' Other Gross PP&E Adjustments amounted to -$33.6 million in Q3 2025, which was up 2659.41% from -$36.8 million recorded in Q2 2025.
- Over the past 5 years, Agios Pharmaceuticals' Other Gross PP&E Adjustments peaked at $4.2 million during Q4 2024, and registered a low of -$82.2 million during Q1 2021.
- Over the past 5 years, Agios Pharmaceuticals' median Other Gross PP&E Adjustments value was -$51.6 million (recorded in 2024), while the average stood at -$49.3 million.
- As far as peak fluctuations go, Agios Pharmaceuticals' Other Gross PP&E Adjustments soared by 1005.69% in 2021, and later skyrocketed by 15421.83% in 2024.
- Agios Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at -$28.4 million in 2021, then soared by 35.63% to -$18.3 million in 2022, then soared by 57.66% to -$7.8 million in 2023, then skyrocketed by 154.22% to $4.2 million in 2024, then tumbled by 900.62% to -$33.6 million in 2025.
- Its Other Gross PP&E Adjustments was -$33.6 million in Q3 2025, compared to -$36.8 million in Q2 2025 and -$39.9 million in Q1 2025.